Sorry, your browser does not support JavaScript!
Find a Treatment Center
Investor Relations
Contact Us
About Us
Our Mission
Our Story
Areas of Focus
Leadership
Kite Locations
Cell Therapy
Our Cell Therapy Technology
Our Therapies
Pipeline
Trials & Expanded Access
Clinical Trial Diversity
External Research Program (ERP)
Patient Resources
Patient Stories
Our Authorized Treatment Centers
Kite Konnect
Newsroom
Newsroom
Press Releases
Company Statements
Media Kit
Careers
Careers
Veteran Careers
Early Talent Programs
Culture & Benefits
Utility
Investor Relations
Contact Us
Kite Konnect®
Contact Us
Find a Treatment Center
Investor Relations
Press Releases
Filter By Year
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017
2026
February 23, 2026
Gilead Sciences to Acquire Arcellx to Maximize Long-Term Potential of Anito-cel
February 06, 2026
FDA Approves Label Update for Kite’s Yescarta® for Relapsed/Refractory Primary Central Nervous System Lymphoma
Filter By Year
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017